» Articles » PMID: 1653277

Altered Transcriptional Regulation of Phosphoenolpyruvate Carboxykinase in Rats Following Endotoxin Treatment

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1991 Sep 1
PMID 1653277
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The molecular mechanism involved in altered regulation of the rate-limiting enzyme in hepatic gluconeogenesis, phosphoenolpyruvate carboxykinase (PEPCK), during endotoxemia is not completely understood. We examined, therefore, the effect of a nonlethal dose of Escherichia coli endotoxin on PEPCK gene expression in fasted rats. 5 h after endotoxin treatment, the PEPCK transcription rate and the amount of mRNA(PEPCK) were significantly decreased at a time when the insulin/glucagon (I/G) molar ratio and plasma corticosterone levels were significantly increased. Similar results were observed in a time course study, in which altered cAMP induction of PEPCK gene expression paralleled changes in the I/G molar ratio. In diabetic rats treated with endotoxin, PEPCK gene expression was decreased in the absence, however, of an increased I/G molar ratio. This finding indicates that other factors, such as inflammatory mediators or cytokines, alter PEPCK gene transcription during endotoxemia. IL-6, a putative mediator of endotoxin action in the liver, had no effect on PEPCK gene expression in fasted rats, but did decrease cAMP induction of PEPCK gene expression. These results indicate that, during endotoxemia, regulation of PEPCK gene expression is influenced by inflammatory mediators in addition to the classical endocrine hormones. IL-6, however, does not appear to be involved directly in the altered regulation of the PEPCK gene during endotoxemia.

Citing Articles

Prophylactic and Therapeutic Efficacy of Boric Acid on Lipopolysaccharide-Induced Liver and Kidney Inflammation in Rats.

Kar E, Kar F, Can B, Cakir Gundogdu A, Ozbayer C, Kocak F Biol Trace Elem Res. 2023; 202(8):3701-3713.

PMID: 37910263 DOI: 10.1007/s12011-023-03941-4.


Impairment of exogenous lactate clearance in experimental hyperdynamic septic shock is not related to total liver hypoperfusion.

Tapia P, Soto D, Bruhn A, Alegria L, Jarufe N, Luengo C Crit Care. 2015; 19:188.

PMID: 25898244 PMC: 4432956. DOI: 10.1186/s13054-015-0928-3.


Glyceroneogenesis is inhibited through HIV protease inhibitor-induced inflammation in human subcutaneous but not visceral adipose tissue.

Leroyer S, Vatier C, Kadiri S, Quette J, Chapron C, Capeau J J Lipid Res. 2010; 52(2):207-20.

PMID: 21068005 PMC: 3023541. DOI: 10.1194/jlr.M000869.


The control of hepatic glycogen metabolism in an in vitro model of sepsis.

Wallington J, Ning J, Titheradge M Mol Cell Biochem. 2007; 308(1-2):183-92.

PMID: 17934698 DOI: 10.1007/s11010-007-9627-y.


Impact of interleukin-6 on the glucose metabolic capacity in rat liver.

Lienenluke B, Christ B Histochem Cell Biol. 2007; 128(4):371-7.

PMID: 17805558 DOI: 10.1007/s00418-007-0327-1.


References
1.
Petersen D, Koch S, GRANNER D . 3' noncoding region of phosphoenolpyruvate carboxykinase mRNA contains a glucocorticoid-responsive mRNA-stabilizing element. Proc Natl Acad Sci U S A. 1989; 86(20):7800-4. PMC: 298158. DOI: 10.1073/pnas.86.20.7800. View

2.
Van Snick J, Cayphas S, Vink A, Uyttenhove C, Coulie P, Rubira M . Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci U S A. 1986; 83(24):9679-83. PMC: 387204. DOI: 10.1073/pnas.83.24.9679. View

3.
Stith R, McCallum R . Failure of glucagon to induce hepatic phosphoenolpyruvate carboxykinase in endotoxic shock. Circ Shock. 1988; 26(3):267-72. View

4.
Jablons D, Mule J, McIntosh J, Sehgal P, May L, Huang C . IL-6/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humans. J Immunol. 1989; 142(5):1542-7. View

5.
Hod Y, Hanson R . Cyclic AMP stabilizes the mRNA for phosphoenolpyruvate carboxykinase (GTP) against degradation. J Biol Chem. 1988; 263(16):7747-52. View